As the world reels from the emergence of the Omicron variant of the coronavirus, a panel of advisers to the Food and Drug Administration will meet on Tuesday to discuss an antiviral pill from Merck, the first in a new class of treatments that could work against a wide range of variants.The expert committee will…
